Article info
PDFOriginal research
Prophylactic efficacy on periprosthetic bone loss in calcar region after total hip arthroplasty of antiosteoporotic drugs: a network meta-analysis of randomised controlled studies
- Correspondence to Dr Yunxian Yu, Department of Public Health, Zhejiang University - Zijingang Campus, Hangzhou 310058, China; yunxianyu{at}zju.edu.cn
Citation
Prophylactic efficacy on periprosthetic bone loss in calcar region after total hip arthroplasty of antiosteoporotic drugs: a network meta-analysis of randomised controlled studies
Publication history
- Received September 13, 2019
- Revised January 21, 2020
- Accepted February 7, 2020
- First published February 29, 2020.
Online issue publication
February 19, 2021
Article Versions
- Previous version (29 February 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.